A citation-based method for searching scientific literature

Eirik Viste, Cathrine Alvaer Vinje, Torgeir Gilje Lid, Svein Skeie, Øystein Evjen-Olsen, Tobias Nordström, Olav Thorsen, Bjørnar Gilje, Emiel A M Janssen, Svein R Kjosavik. Scand J Prim Health Care 2020
Times Cited: 6







List of co-cited articles
58 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Prostate cancer screening in men aged 50-69 years (STHLM3): a prospective population-based diagnostic study.
Henrik Grönberg, Jan Adolfsson, Markus Aly, Tobias Nordström, Peter Wiklund, Yvonne Brandberg, James Thompson, Fredrik Wiklund, Johan Lindberg, Mark Clements,[...]. Lancet Oncol 2015
199
66

The Stockholm-3 (STHLM3) Model can Improve Prostate Cancer Diagnostics in Men Aged 50-69 yr Compared with Current Prostate Cancer Testing.
Martin Eklund, Tobias Nordström, Markus Aly, Jan Adolfsson, Peter Wiklund, Yvonne Brandberg, James Thompson, Fredrik Wiklund, Johan Lindberg, Joseph C Presti,[...]. Eur Urol Focus 2018
26
50


Artificial intelligence for diagnosis and grading of prostate cancer in biopsies: a population-based, diagnostic study.
Peter Ström, Kimmo Kartasalo, Henrik Olsson, Leslie Solorzano, Brett Delahunt, Daniel M Berney, David G Bostwick, Andrew J Evans, David J Grignon, Peter A Humphrey,[...]. Lancet Oncol 2020
97
33


Inactivation of CDK12 Delineates a Distinct Immunogenic Class of Advanced Prostate Cancer.
Yi-Mi Wu, Marcin Cieślik, Robert J Lonigro, Pankaj Vats, Melissa A Reimers, Xuhong Cao, Yu Ning, Lisha Wang, Lakshmi P Kunju, Navonil de Sarkar,[...]. Cell 2018
223
33


Prostate-specific antigen (PSA) density in the diagnostic algorithm of prostate cancer.
Tobias Nordström, Olof Akre, Markus Aly, Henrik Grönberg, Martin Eklund. Prostate Cancer Prostatic Dis 2018
47
33

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
Freddie Bray, Jacques Ferlay, Isabelle Soerjomataram, Rebecca L Siegel, Lindsey A Torre, Ahmedin Jemal. CA Cancer J Clin 2018
33

Potential impact of adding genetic markers to clinical parameters in predicting prostate biopsy outcomes in men following an initial negative biopsy: findings from the REDUCE trial.
A Karim Kader, Jielin Sun, Brian H Reck, Paul J Newcombe, Seong-Tae Kim, Fang-Chi Hsu, Ralph B D'Agostino, Sha Tao, Zheng Zhang, Aubrey R Turner,[...]. Eur Urol 2012
75
33

The use of prostate specific antigen density to predict clinically significant prostate cancer.
Igor Yusim, Muhammad Krenawi, Elad Mazor, Victor Novack, Nicola J Mabjeesh. Sci Rep 2020
5
40

Re-examining Prostate-specific Antigen (PSA) Density: Defining the Optimal PSA Range and Patients for Using PSA Density to Predict Prostate Cancer Using Extended Template Biopsy.
Joshua S Jue, Marcelo Panizzutti Barboza, Nachiketh S Prakash, Vivek Venkatramani, Varsha R Sinha, Nicola Pavan, Bruno Nahar, Pratik Kanabur, Michael Ahdoot, Yan Dong,[...]. Urology 2017
33
33

A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer.
Ali Amin Al Olama, Zsofia Kote-Jarai, Sonja I Berndt, David V Conti, Fredrick Schumacher, Ying Han, Sara Benlloch, Dennis J Hazelett, Zhaoming Wang, Ed Saunders,[...]. Nat Genet 2014
284
33

Optimizing patient's selection for prostate biopsy: A single institution experience with multi-parametric MRI and the 4Kscore test for the detection of aggressive prostate cancer.
Sanoj Punnen, Bruno Nahar, Nachiketh Soodana-Prakash, Tulay Koru-Sengul, Radka Stoyanova, Alan Pollack, Bruce Kava, Mark L Gonzalgo, Chad R Ritch, Dipen J Parekh. PLoS One 2018
24
33

Urinary PCA3 detection in prostate cancer by magnetic nanoparticles coupled with colorimetric enzyme-linked oligonucleotide assay.
Vichanan Yamkamon, Khin Phyu Pyar Htoo, Sakda Yainoy, Thummaruk Suksrichavalit, Tienrat Tangchaikeeree, Warawan Eiamphungporn. EXCLI J 2020
4
50

Detection of High-grade Prostate Cancer Using a Urinary Molecular Biomarker-Based Risk Score.
Leander Van Neste, Rianne J Hendriks, Siebren Dijkstra, Geert Trooskens, Erik B Cornel, Sander A Jannink, Hans de Jong, Daphne Hessels, Frank P Smit, Willem J G Melchers,[...]. Eur Urol 2016
178
33

Risk score predicts high-grade prostate cancer in DNA-methylation positive, histopathologically negative biopsies.
Leander Van Neste, Alan W Partin, Grant D Stewart, Jonathan I Epstein, David J Harrison, Wim Van Criekinge. Prostate 2016
41
33

The 4Kscore® Test Reduces Prostate Biopsy Rates in Community and Academic Urology Practices.
Badrinath Konety, Stephen M Zappala, Dipen J Parekh, Danielle Osterhout, Jeffrey Schock, Randy M Chudler, Gregory M Oldford, Kenneth M Kernen, Jason Hafron. Rev Urol 2015
28
33

A urine-based Exosomal gene expression test stratifies risk of high-grade prostate Cancer in men with prior negative prostate biopsy undergoing repeat biopsy.
James McKiernan, Mikkel Noerholm, Vasisht Tadigotla, Sonia Kumar, Phillipp Torkler, Grannum Sant, Jason Alter, Michael J Donovan, Johan Skog. BMC Urol 2020
6
33

Clinical utility of an epigenetic assay to detect occult prostate cancer in histopathologically negative biopsies: results of the MATLOC study.
Grant D Stewart, Leander Van Neste, Philippe Delvenne, Paul Delrée, Agnès Delga, S Alan McNeill, Marie O'Donnell, James Clark, Wim Van Criekinge, Joseph Bigley,[...]. J Urol 2013
135
33

Evaluating the Four Kallikrein Panel of the 4Kscore for Prediction of High-grade Prostate Cancer in Men in the Canary Prostate Active Surveillance Study.
Daniel W Lin, Lisa F Newcomb, Marshall D Brown, Daniel D Sjoberg, Yan Dong, James D Brooks, Peter R Carroll, Matthew Cooperberg, Atreya Dash, William J Ellis,[...]. Eur Urol 2017
48
33

Use of the Prostate Health Index and Density in 3 Outpatient Centers to Avoid Unnecessary Prostate Biopsies.
Anni Schulze, Frank Christoph, Markus Sachs, Joerg Schroeder, Carsten Stephan, Martin Schostak, Frank Koenig. Urol Int 2020
3
66

Combining urinary detection of TMPRSS2:ERG and PCA3 with serum PSA to predict diagnosis of prostate cancer.
Simpa S Salami, Folke Schmidt, Bharathi Laxman, Meredith M Regan, David S Rickman, Douglas Scherr, Gerardina Bueti, Javed Siddiqui, Scott A Tomlins, John T Wei,[...]. Urol Oncol 2013
130
33

A urinary biomarker-based risk score correlates with multiparametric MRI for prostate cancer detection.
Rianne J Hendriks, Marloes M G van der Leest, Siebren Dijkstra, Jelle O Barentsz, Wim Van Criekinge, Christina A Hulsbergen-van de Kaa, Jack A Schalken, Peter F A Mulders, Inge M van Oort. Prostate 2017
44
33

Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer.
Scott A Tomlins, Daniel R Rhodes, Sven Perner, Saravana M Dhanasekaran, Rohit Mehra, Xiao-Wei Sun, Sooryanarayana Varambally, Xuhong Cao, Joelle Tchinda, Rainer Kuefer,[...]. Science 2005
33

Value of PCA3 to predict biopsy outcome and its potential role in selecting patients for multiparametric MRI.
Gisele H J M Leyten, Elisabeth A Wierenga, J P Michiel Sedelaar, Inge M van Oort, Jurgen J Futterer, Jelle O Barentsz, Jack A Schalken, Peter F A Mulders. Int J Mol Sci 2013
21
33

The prostate health index selectively identifies clinically significant prostate cancer.
Stacy Loeb, Martin G Sanda, Dennis L Broyles, Sanghyuk S Shin, Chris H Bangma, John T Wei, Alan W Partin, George G Klee, Kevin M Slawin, Leonard S Marks,[...]. J Urol 2015
140
33

A multicenter study of [-2]pro-prostate specific antigen combined with prostate specific antigen and free prostate specific antigen for prostate cancer detection in the 2.0 to 10.0 ng/ml prostate specific antigen range.
William J Catalona, Alan W Partin, Martin G Sanda, John T Wei, George G Klee, Chris H Bangma, Kevin M Slawin, Leonard S Marks, Stacy Loeb, Dennis L Broyles,[...]. J Urol 2011
286
33

Detection of the Prostate Cancer Biomarker PCA3 with Electrochemical and Impedance-Based Biosensors.
Juliana Coatrini Soares, Andrey Coatrini Soares, Valquiria Cruz Rodrigues, Matias Eliseo Melendez, Alexandre Cesar Santos, Eliney Ferreira Faria, Rui M Reis, Andre Lopes Carvalho, Osvaldo N Oliveira. ACS Appl Mater Interfaces 2019
15
33

Prostate-specific antigen (PSA) isoform p2PSA in combination with total PSA and free PSA improves diagnostic accuracy in prostate cancer detection.
Flip H Jansen, Ron H N van Schaik, Joep Kurstjens, Wolfgang Horninger, Helmut Klocker, Jasmin Bektic, Mark F Wildhagen, Monique J Roobol, Chris H Bangma, Georg Bartsch. Eur Urol 2010
163
33

A Multicentre Evaluation of the Role of the Prostate Health Index (PHI) in Regions with Differing Prevalence of Prostate Cancer: Adjustment of PHI Reference Ranges is Needed for European and Asian Settings.
Peter K-F Chiu, Chi-Fai Ng, Axel Semjonow, Yao Zhu, Sébastien Vincendeau, Alain Houlgatte, Massimo Lazzeri, Giorgio Guazzoni, Carsten Stephan, Alexander Haese,[...]. Eur Urol 2019
38
33

Multicenter Optimization and Validation of a 2-Gene mRNA Urine Test for Detection of Clinically Significant Prostate Cancer before Initial Prostate Biopsy.
Alexander Haese, Geert Trooskens, Sandra Steyaert, Daphne Hessels, Michael Brawer, Virginie Vlaeminck-Guillem, Alain Ruffion, Derya Tilki, Jack Schalken, Jack Groskopf,[...]. J Urol 2019
32
33

Incorporating Biomarkers into the Primary Prostate Biopsy Setting: A Cost-Effectiveness Analysis.
Niranjan J Sathianathen, Karen M Kuntz, Fernando Alarid-Escudero, Nathan L Lawrentschuk, Damien M Bolton, Declan G Murphy, Christopher J Weight, Badrinath R Konety. J Urol 2018
22
33

Clinical utility of the exosome based ExoDx Prostate(IntelliScore) EPI test in men presenting for initial Biopsy with a PSA 2-10 ng/mL.
Ronald Tutrone, Michael J Donovan, Phillipp Torkler, Vasisht Tadigotla, Tom McLain, Mikkel Noerholm, Johan Skog, James McKiernan. Prostate Cancer Prostatic Dis 2020
32
33

The Four-Kallikrein Panel Is Effective in Identifying Aggressive Prostate Cancer in a Multiethnic Population.
Burcu F Darst, Alisha Chou, Peggy Wan, Loreall Pooler, Xin Sheng, Emily A Vertosick, David V Conti, Lynne R Wilkens, Loïc Le Marchand, Andrew J Vickers,[...]. Cancer Epidemiol Biomarkers Prev 2020
13
33

A Novel Urine Exosome Gene Expression Assay to Predict High-grade Prostate Cancer at Initial Biopsy.
James McKiernan, Michael J Donovan, Vince O'Neill, Stefan Bentink, Mikkel Noerholm, Susan Belzer, Johan Skog, Michael W Kattan, Alan Partin, Gerald Andriole,[...]. JAMA Oncol 2016
260
33

The Stockholm3 blood-test predicts clinically-significant cancer on biopsy: independent validation in a multi-center community cohort.
Axel Möller, Henrik Olsson, Henrik Grönberg, Martin Eklund, Markus Aly, Tobias Nordström. Prostate Cancer Prostatic Dis 2019
10
33

Can urinary PCA3 supplement PSA in the early detection of prostate cancer?
John T Wei, Ziding Feng, Alan W Partin, Elissa Brown, Ian Thompson, Lori Sokoll, Daniel W Chan, Yair Lotan, Adam S Kibel, J Erik Busby,[...]. J Clin Oncol 2014
161
33

Diagnostic accuracy of prostate cancer antigen 3 (PCA3) prior to first prostate biopsy: A systematic review and meta-analysis.
Sandra Viviana Muñoz Rodríguez, Herney Andrés García-Perdomo. Can Urol Assoc J 2020
8
33

A Prospective Adaptive Utility Trial to Validate Performance of a Novel Urine Exosome Gene Expression Assay to Predict High-grade Prostate Cancer in Patients with Prostate-specific Antigen 2-10ng/ml at Initial Biopsy.
James McKiernan, Michael J Donovan, Eric Margolis, Alan Partin, Ballentine Carter, Gordon Brown, Phillipp Torkler, Mikkel Noerholm, Johan Skog, Neal Shore,[...]. Eur Urol 2018
85
33

Clinical utility of the Prostate Health Index (phi) for biopsy decision management in a large group urology practice setting.
Jay White, B Vittal Shenoy, Ronald F Tutrone, Lawrence I Karsh, Daniel R Saltzstein, William J Harmon, Dennis L Broyles, Tamra E Roddy, Lori R Lofaro, Carly J Paoli,[...]. Prostate Cancer Prostatic Dis 2018
20
33

Cost-effectiveness of SelectMDx for prostate cancer in four European countries: a comparative modeling study.
Tim M Govers, Daphne Hessels, Virginie Vlaeminck-Guillem, Bernd J Schmitz-Dräger, Christian G Stief, Claudio Martinez-Ballesteros, Matteo Ferro, Angel Borque-Fernando, Jose Rubio-Briones, J P Michiel Sedelaar,[...]. Prostate Cancer Prostatic Dis 2019
28
33

Urinary PCA3 as a predictor of prostate cancer in a cohort of 3,073 men undergoing initial prostate biopsy.
K Kent Chevli, Michael Duff, Peter Walter, Changhong Yu, Brian Capuder, Ahmed Elshafei, Stephanie Malczewski, Michael W Kattan, J Stephen Jones. J Urol 2014
68
33

Reducing unnecessary biopsies while detecting clinically significant prostate cancer including cribriform growth with the ERSPC Rotterdam risk calculator and 4Kscore.
Jan F M Verbeek, Chris H Bangma, Charlotte F Kweldam, Theodorus H van der Kwast, Intan P Kümmerlin, Geert J L H van Leenders, Monique J Roobol. Urol Oncol 2019
20
33

Comparison Between the Four-kallikrein Panel and Prostate Health Index for Predicting Prostate Cancer.
Tobias Nordström, Andrew Vickers, Melissa Assel, Hans Lilja, Henrik Grönberg, Martin Eklund. Eur Urol 2015
112
33

A multi-institutional prospective trial in the USA confirms that the 4Kscore accurately identifies men with high-grade prostate cancer.
Dipen J Parekh, Sanoj Punnen, Daniel D Sjoberg, Scott W Asroff, James L Bailen, James S Cochran, Raoul Concepcion, Richard D David, Kenneth B Deck, Igor Dumbadze,[...]. Eur Urol 2015
216
33

Evaluation of an Epigenetic Assay for Predicting Repeat Prostate Biopsy Outcome in African American Men.
Robert L Waterhouse, Leander Van Neste, Kelvin A Moses, Carlton Barnswell, Jonathan L Silberstein, Mark Jalkut, Ronald Tutrone, James Sylora, Ronald Anglade, Myron Murdock,[...]. Urology 2019
9
33

Clinical validation of an epigenetic assay to predict negative histopathological results in repeat prostate biopsies.
Alan W Partin, Leander Van Neste, Eric A Klein, Leonard S Marks, Jason R Gee, Dean A Troyer, Kimberly Rieger-Christ, J Stephen Jones, Cristina Magi-Galluzzi, Leslie A Mangold,[...]. J Urol 2014
124
33

Multicenter Evaluation of the Prostate Health Index to Detect Aggressive Prostate Cancer in Biopsy Naïve Men.
Claire de la Calle, Dattatraya Patil, John T Wei, Douglas S Scherr, Lori Sokoll, Daniel W Chan, Javed Siddiqui, Juan Miguel Mosquera, Mark A Rubin, Martin G Sanda. J Urol 2015
92
33

Prostate Health Index density improves detection of clinically significant prostate cancer.
Jeffrey J Tosoian, Sasha C Druskin, Darian Andreas, Patrick Mullane, Meera Chappidi, Sarah Joo, Kamyar Ghabili, Mufaddal Mamawala, Joseph Agostino, Herbert B Carter,[...]. BJU Int 2017
39
33


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.